Abstract
Parkinson’s disease (PD) is the second most common neurodegenerative disorder and is characterized by resting tremor, bradykinesia, rigidity, and postural and gait instability. Pathology related to the disease itself, as well as the medications used to treat it, presents unique problems, which make inpatient and perioperative care of PD patients challenging. Suboptimal management can lead to perioperative complications, prolonged hospitalization, and delayed recovery from surgery. Anticipating potential complications and taking steps to prevent these can improve safety and quality of care for PD patients.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
parkinson.org, Parkinson’s foundation understanding parkinson’s causes and statistics. 2018. http://www.parkinson.org/Understanding-Parkinsons/Causes-and-Statistics/Statistics. Accessed June 16.
Gerlach OH, Winogrodzka A, Weber WE. Clinical problems in the hospitalized Parkinson’s disease patient: systematic review. Mov Disord. 2011;26:197–208.
Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep. 2012;61:1–51.
Dorsey ER, Bloem BR. The Parkinson pandemic-a call to action. JAMA Neurol. 2018;75:9–10.
Brennan KA, Genever RW. Managing Parkinson’s disease during surgery. BMJ. 2010;341:c5718.
Reilly DF, McNeely MJ, Doerner D, Greenberg DL, Staiger TO, Geist MJ, Vedovatti PA, Coffey JE, Mora MW, Johnson TR, Guray ED, Van Norman GA, Fihn SD. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med. 1999;159:2185–92.
Fox A, Aseeri M, Delayed administration and contraindicated drugs place hospitalized Parkinson’s disease patients at risk, Institute for Safe Medication Practices. https://www.ismp.org/resources/delayed-administration-and-contraindicated-drugs-place-hospitalized-parkinsons-disease. Accessed 16 June 2018.
Mariscal A, Hernández Medrano I, Alonso Canovas A, Lobo E, Loinaz C, Vela L, Garcia-Ruiz Espiga P, Martinez Castrillo JC. Perioperative management of Parkinson’s disease. Neurologia. 2012;27:46–50.
Lees AJ, Hardy J, Revesz T. Parkinson’s disease. Lancet. 2009;373:2055–66.
Quinn R, How should Parkinson’s disease be managed perioperatively?, The Hospitalist. https://www.the-hospitalist.org/hospitalist/article/124294/how-should-parkinsons-disease-be-managed-perioperatively. Accessed 1 Dec 2011.
Mueller MC, Juptner U, Wuellner U, Wirz S, Turler A, Hirner A, Standop J. Parkinson’s disease influences the perioperative risk profile in surgery. Langenbecks Arch Surg. 2009;394:511–5.
Zesiewicz TA, Sullivan KL, Arnulf I, Chaudhuri KR, Morgan JC, Gronseth GS, Miyasaki J, Iverson DJ, Weiner WJ, Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74:924–31.
Newman EJ, Grosset DG, Kennedy PG. The parkinsonism-hyperpyrexia syndrome. Neurocrit Care. 2009;10:136–40.
Fujii T, Nakabayashi T, Hashimoto S, Kuwano H. Successful perioperative management of patients with Parkinson’s disease following gastrointestinal surgery: report of three cases. Surg Today. 2009;39:807–10.
Julius A, Longfellow K. Movement disorders: a brief guide in medication management. Med Clin North Am. 2016;100:733–61.
Wullner U, Kassubek J, Odin P, Schwarz M, Naumann M, Hack HJ, Boroojerdi B, Reichmann H, Group NS. Transdermal rotigotine for the perioperative management of Parkinson’s disease. J Neural Transm (Vienna). 2010;117:855–9.
Burton DA, Nicholson G, Hall GM. Anaesthesia in elderly patients with neurodegenerative disorders: special considerations. Drugs Aging. 2004;21:229–42.
Meyring K, Zehnder A, Schmid RA, Kocher GJ. Thoracic surgery in patients with an implanted neurostimulator device. Interact Cardiovasc Thorac Surg. 2017;25:667–8.
Medtronic.com, Medtronic® DBS™ Therapy implanted neurostimulators - information for prescribers. http://manuals.medtronic.com/manuals/main/en_US/manual/therapy?therapy=DBS+for+Parkinsons. Accessed 17 June 2018.
Tavernier R, Fonteyne W, Vandewalle V, de Sutter J, Gevaert S. Use of an implantable cardioverter defibrillator in a patient with two implanted neurostimulators for severe Parkinson’s disease. Pacing Clin Electrophysiol. 2000;23:1057–9.
Katus L, Shtilbans A. Perioperative management of patients with Parkinson’s disease. Am J Med. 2014;127:275–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Khalighi, M., Kaplan, E., Kim, H. (2020). Parkinson’s Disease. In: Jackson, M., Huang, R., Kaplan, E., Mookherjee, S. (eds) The Perioperative Medicine Consult Handbook. Springer, Cham. https://doi.org/10.1007/978-3-030-19704-9_30
Download citation
DOI: https://doi.org/10.1007/978-3-030-19704-9_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-19703-2
Online ISBN: 978-3-030-19704-9
eBook Packages: MedicineMedicine (R0)